Clinical trial
Electroconvulsive Therapy and Concomitant Lithium in Depression: a Double-blind Randomized Controlled Pilot Study
NCT05923476 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Electroconvulsive Therapy and Concomitant Lithium in Depression: a Double-blind Randomized Controlled Pilot Study
- Lead sponsor
- Melbourne Health
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- June 1, 2023
- Completion date
- June 30, 2025
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.